Rare diseases
Investigational molecules
Locations
20 Rue Leblanc, 75015 Paris, France
Research activity in kidney cancer focuses on metastatic renal cell carcinoma and treatment selection informed by molecular subgroups. The clinical interest includes immunotherapy with nivolumab and ipilimumab, as well as targeted therapy with tyrosine kinase inhibitors such as sunitinib and pazopanib.
The sponsor’s work in this area is centered on comparing treatment approaches across biologically defined disease groups in advanced kidney malignancy.
ARTIC runs clinical trials in conditions such as Renal cancer, Prostate cancer, Metastases to lymph nodes, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
